Avis Budget Group Inc (NASDAQ: CAR) Up 79.02% YTD: Could Trouble Be Ahead?
Avis Budget Group Inc (NASDAQ:CAR)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting 2.20. At the close
Avis Budget Group Inc (NASDAQ:CAR)’s traded shares stood at 0.74 million during the last session, with the company’s beta value hitting 2.20. At the close
Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s traded shares stood at 0.61 million during the last session, with the company’s beta value hitting 0.73. At the close
Achieve Life Sciences Inc (NASDAQ:ACHV)’s traded shares stood at 0.82 million during the last session, with the company’s beta value hitting 1.30. At the close
Veru Inc (NASDAQ:VERU)’s traded shares stood at 0.9 million during the last session, with the company’s beta value hitting -0.69. At the close of trading,
Black Diamond Therapeutics Inc (NASDAQ:BDTX)’s traded shares stood at 0.47 million during the last session, with the company’s beta value hitting 2.87. At the close
NewAmsterdam Pharma Company NV (NASDAQ:NAMS)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting -0.03. At the close
Voyager Therapeutics Inc (NASDAQ:VYGR)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 0.90.The VYGR share’s 52-week high
Passage Bio Inc (NASDAQ:PASG)’s traded shares stood at 0.5 million during the last session, with the company’s beta value hitting 1.82. At the close of
Pyxis Oncology Inc (NASDAQ:PYXS)’s traded shares stood at 0.5 million during the last session, with the company’s beta value hitting 1.12. At the close of
PMV Pharmaceuticals Inc (NASDAQ:PMVP)’s traded shares stood at 0.58 million during the last session, with the company’s beta value hitting 1.48. At the close of
© 2024, Powered by Smart TechOne